Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1043P is a pseudogene derived from the U6 small nuclear RNA gene. Unlike the functional U6 snRNA, which is an essential component of the spliceosome catalyzing intron removal in pre-mRNA splicing[1][3], pseudogenes like RNU6-1043P result from retrotransposition events and do not encode functional RNAs or proteins[5][7]. Such pseudogenes are highly conserved, present in multiple copies in vertebrate genomes, and may serve as markers for retrotransposition dynamics and genome evolution but lack known biological, pharmacological, or disease association as typical *targets*[7][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1043, pseudogene (RNU6-1043P).